One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-139416
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 2 |
Affiliation: University of Bologna, University of Tennessee at Knoxville, Humanitas University, Istituti di Ricovero e Cura a Carattere Scientifico, The Maria Sklodowska-Curie National Research Institute of Oncology, University of Sydney, Jewish General Hospital, Hospital Santa Marcelina, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Hospital Israelita Albert Einstein, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Ankara University, National Hospital Organization, MSD (United States), Princess Margaret Cancer Centre
Effect of Pembrolizumab Monotherapy Versus Brentuximab Vedotin (BV) on Symptoms Associated with Health-Related Quality of Life (HRQoL) in Relapsed/Refractory (R/R) Classical Hodgkin Lymphoma (cHL) in the Randomized, Phase 3, Keynote-204 Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
